Loading...

Biocept, Inc.

BIOC•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.43
$0.00(0.00%)

Biocept, Inc. (BIOC) Stock Overview

Explore Biocept, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.0/100

Key Financials

Market Cap450.8K
P/E Ratio-0.01
EPS (TTM)$-48.17
ROE-1.38%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.19

BIOC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biocept, Inc. (BIOC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 450.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;